Clinical Trial Update: A Platform Study of Novel Agents in Combination With Radiotherapy in NSCLC [Phase 1]

View source ↗

Summary

A Phase 1 platform trial evaluating novel agents in combination with radiotherapy for non-small cell lung cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University of Leeds | Conditions: Non Small Cell Lung Cancer | Phase 1 | Status: RECRUITING